Elekta Collaborates with Algeria to Bring New Hope to Cancer Patients

STOCKHOLM--()--Regulatory News:

Elekta (STO:EKTAB):

In efforts to treat more cancer patients, more effectively, Algeria’s Ministry of Health, Population and Hospital Reform (MoHPHR) launched an ambitious plan in 2013 to equip or build 13 new cancer centers over the next five years. The Ministry has announced that this plan includes the purchase of a variety of hardware and software solutions from Elekta, including training at each of the centers.

Ian Alexander, Executive Vice President Region Europe, Africa, Latin America and the Middle East says: “The MoHPHR has reported the number of new cancer cases at 44,000 annually, making it the second leading cause of death in Algeria after cardiovascular illnesses. We are proud that Elekta has been chosen to help close the gap between treatment needs and treatment capacity.”

Modernizing cancer care in Algeria is part of the government’s fight against non-communicable diseases in accordance with the UN Millennium Development Goals. This modernization will be realized with Elekta Synergy® and Versa HD™ linear accelerators, MOSAIQ® oncology information systems, treatment planning systems using Elekta’s Monaco®, as well as training for the clinicians using the hardware and software. Seven cancer centers will receive Elekta equipment.

The entire deal, which was booked during Elekta’s second fiscal quarter, is valued at around SEK 250 million.

# # #

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 11:00 CET on January 14, 2014.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO: EKTAB. Website: www.elekta.com.

This information was brought to you by Cision http://news.cision.com

Contacts

Elekta AB
Gert van Santen, Group Vice President
Corporate Communications
Tel: +31 653 561 242
e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
ot
Michelle Joiner, Director, Global Public Relations and Brand Management
Tel: +1 770-670-2447
e-mail: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

Sharing

Contacts

Elekta AB
Gert van Santen, Group Vice President
Corporate Communications
Tel: +31 653 561 242
e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
ot
Michelle Joiner, Director, Global Public Relations and Brand Management
Tel: +1 770-670-2447
e-mail: michelle.joiner@elekta.com
Time zone: ET: Eastern Time